Keeping current with the retina literature is, for most, an ongoing, futile effort. New journals are constantly being introduced, and existing journals keep getting thicker and thicker. Researching a topic on PubMed doesn’t allow you to spot key references or quickly digest what’s new globally on a topic of interest. And remembering what you’ve read a few weeks later (or even after you’ve turned the page to the next article) is a struggle.
To address these concerns, we pull key clinical references from 24 major ophthalmic and retinal journals each month (click here for the journal list). Although we can’t provide the journal article PDF due to copyright issues, we provide a single-line citation with a brief summary of the article’s main points. Our goal is to capture all major clinically relevant references.
Please contact us if we’re missing any key references or if any reference is mis-summarized or cited.
That’s easy! Just subscribe to the Retina World Congress’s monthly email blast here.
At the top of most Image Library folders is a ___References Word document containing the annotated bibliography for that topic. Every month, we file key articles into the appropriate Retina Rocks folder(s) and update this file. Key articles are located at the top of the list. This allows for a rapid snapshot and review of the literature while also looking through our multimedia images. Some seemingly unrelated references are included in each folder to aid in differential diagnosis or to learn about similar findings in other disorders.
Here is the current month's snapshot of key retina journal articles
Retina. 2026 Oct 1;46(10):1740-1747. doi: 10.1097/IAE.0000000000004914.
Persistent placoid maculopathy: Final VA worse than 20-100 in one-third of eyes; MNV in 65%; Systemic cardiovascular comorbidities in 88%; Disease reactivation common — Retrospective, at least 23-month FU, 23 patients
JAMA Ophthalmol. 2026 Oct 1;144(10):925-933. doi: 10.1001/jamaophthalmol.2026.3684.
High myopia Longitudinal trajectories of 15-year 3D eye shape with pathologic sequelae. Axial length alone doesn’t reflect non-spheroidal contour — 30 patients, With editorial
Int Ophthalmol. 2026 Oct 12;46(1):417. doi: 10.1007/s10792-026-04287-1.
1st-episode ICSC: Oral eplerenone (vs placebo) enhanced fluid resolution but no change in VA at 3 months — Prospective, double-masked RCT, 44 patients
Retina. 2026 Oct 1;46(10):1733-1739. doi: 10.1097/IAE.0000000000004918.
PED in severe APMPPE is associated with worse initial VA, bacillary layer detachment, and serous RD. PED biomarker for severe disease and choriocapillaris ischemia — Retrospective, 46 eyes
Eye (Lond). 2026 Oct;40(14):2199-2205. doi: 10.1038/s41433-026-04686-9.
nAMD Switch to Vabysmo VA stable with decreased fluid and treatment burden. Initial matching interval dosing (rather than re-load) effective — Retrospective, 173 eyes
Eye (Lond). 2026 Oct;40(14):2221-2227. doi: 10.1038/s41433-026-04706-8.
Macular serpiginous (MSC) vs serpiginous-like choroiditis (SLC): MSC more aggressive progression with worse VA prognosis — Retrospective, 30 eyes
Int Ophthalmol. 2026 Sep 24;46(1):402. doi: 10.1007/s10792-026-04262-w.
Iluvien for unresponsive or recurrent DME: Reduced retinal thickness fluctuations with better VA — RIVER study, Retrospective, Portuguese national registry, 97 eyes
Ophthalmol Retina. 2026 Oct;10(10):1009-1016. doi: 10.1016/j.oret.2026.05.021.
Post-RRD repair: Marginal outer retinal ridge OCT biomarker of retinal displacement — Retrospective, 12 eyes
Acta Ophthalmol. 2026 Nov;104(7):e745-e756. doi: 10.1111/aos.70095.
nAMD Prechoroidal cleft: Pathophysiology, clinical implications, and prognosis. Dynamic marker for disease activity — Review
Ophthalmic Surg Lasers Imaging Retina. 2026 Oct;57(10):625-632. doi: 10.3928/23258160-20260819-01.
Toxic posterior segment syndrome post dropless cataract surgery with compounded triamcinolone-moxifloxacin — Retrospective, 50 eyes from 2017 outbreak
Eye (Lond). 2026 Oct;40(15):2360-2366. doi: 10.1038/s41433-026-04617-8.
iAMD Hyperreflective foci and subretinal drusenoid deposits load accelerate progression to exudative MNV in high-risk fellow eyes — Post hoc, EDNA database
Indian J Ophthalmol. 2026 Oct 1;74(Suppl 3):S464-S470. doi: 10.4103/IJO.IJO_565_25.
Early silicone oil emulsification post-PPV RD is more common with suboptimal oil fill — Retrospective, 81 eyes
Eye (Lond). 2026 Oct;40(14):2215-2220. doi: 10.1038/s41433-026-04697-6.
PCV New polyps develop in 33% of eyes (80% de novo) undergoing anti-VEGF treat-extend — Retrospective, 45 eyes
Can J Ophthalmol. 2026 Oct;61(5):1181-1190. doi: 10.1016/j.jcjo.2026.04.006.
Post-uveal MM plaque 30 years post-surgery, fewer than 1 in 20 eyes retained usual VA. Results not altered after analyzing post-2010 patients within anti-VEGF era — Retrospective, 1785 Swedish patients
Acta Ophthalmol. 2026 Nov;104(7):e803-e809. doi: 10.1111/aos.70150.
nAMD Vision-related quality of life stable with unilateral disease, but decreased without recovery in 2nd eye — FASTBAT, 424 patients
Ophthalmol Retina. 2026 Oct;10(10):1047-1055. doi: 10.1016/j.oret.2026.06.001.
RAM Clinical features, management and outcomes. Most spontaneously improve, BUT selective treatment for more severe presentations may be beneficial — Retrospective, BPEI, 161 eyes
Retina. 2026 Oct 1;46(10):1644-1651. doi: 10.1097/IAE.0000000000004853.
Macular PVD commonly involves circumferential cortical tearing (rather than detachment) due to shallow angle of tractional forces. May contribute to subsequent ERM formation —Retrospective, volume-rendered SS-OCT, 53 eyes
Surv Ophthalmol. 2026 Sep-Oct;71(5):1249-1260. doi: 10.1016/j.survophthal.2026.03.008.
Acute ICSC: PDT effective; Anti-VEGF transient 1-month decreased fluid without sustained VA or anatomic benefits — Systematic review and meta-analysis
Eye (Lond). 2026 Oct;40(15):2313-2314. doi: 10.1038/s41433-026-04812-7.
Editorial argues against prophylactic antibiotic use for intravitreal injections – Use does not reduce infection risk, increases drug resistance, and adds cost.
Eye (Lond). 2026 Oct;40(14):2187-2192. doi: 10.1038/s41433-026-04699-4.
Diabetic retinopathy screening in 80YO or older: 0.11% needed DME treatment, and no PDR identified. Suggests routine screening for this population should be reconsidered — Retrospective, 3599 patients
Acta Ophthalmol. 2026 Nov;104(7):731-741. doi: 10.1111/aos.70127.
PPV RRD 360-degree (vs focal laser) higher single-surgery success but similar VA. Need well-designed RCTs to confirm the magnitude of benefit — Systematic review and Meta-analysis.
Receive Retina Rocks content in the RWC monthly newsletter!
Retina Rocks is the image bank of the Retina World Congress.